Courtagen Submits Pre-IDE Information Package for the Avantra® Q400 Workstation and QPDx® BioChip
May 9, 2012
WOBURN, Mass.,-- Courtagen Life Sciences, Inc., a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, today announced that the company has submitted its first pre- IDE (Investigational Device Exemption) information package to the U.S. Food and Drug Administration for the Company’s Avantra® Q400 BioMarker [...]
May 9, 2012
Bournemouth, UK –Solentim, the provider of high resolution imaging for fast clone selection, has introduced the new Cell Metric™ CLD bench top system, optimised to provide fast, reliable and automated cell line development (CLD). The high resolution offered by Cell Metric’s unique cell imaging and analysis system offers an alternative approach to manually checking cell [...]
May 9, 2012
Charlottesville, VA – ZyGEM Corp. Ltd., a developer and marketer of innovative products for the analysis of DNA and RNA, today announced that it has entered into an agreement with Quanta BioSciences to incorporate ZyGEM’s advanced enzymatic RNA extraction technology into Quanta’s leading reagents for quantitative PCR sold to customers worldwide. The collaboration will enable [...]
May 9, 2012
SAN DIEGO, -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that it has signed an agreement with U.S. health insurance provider Coventry Health Care National Network to provide coverage for the Sequenom Center for Molecular Medicine's (Sequenom CMM) MaterniT21 PLUS laboratory-developed test (LDT). The test detects certain [...]
Microsaic Signs Commercial Agreement with International Partner
May 9, 2012
Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments, is pleased to announce the signing of a significant agreement to provide its miniature mass spectrometer - the Microsaic MiD - as an Original Equipment Manufacturer (OEM) to an international supplier of laboratory equipment. Under the terms of the agreement, the new supplier will [...]
Whole Genome Sequencing in Type 2 Diabetes Genetic Study
May 9, 2012
MOUNTAIN VIEW, Calif.– Complete Genomics Inc. (NASDAQ: GNOM) announced today that it has sequenced the genomes of 600 individuals from 20 Mexican-American families from San Antonio in what is thought to be the largest whole genome sequencing family study conducted to date and the first such study of its kind in a Latino population. “We [...]
Exiqon introduces species specific microRNA qPCR panels for preclinical toxicology research
May 9, 2012
Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of a microRNA qPCR Focus Panel for preclinical toxicology research. The new Toxicology Focus microRNA PCR Panels allow scientists engaged in toxicology research to apply a panel of qPCR microRNA assays optimized for analysis of microRNAs present [...]
LGC Standards acquires VHG Labs Inc
May 9, 2012
LGC Standards, the leading global supplier of reference materials, is pleased to announce that it has acquired US-based VHG Labs, a leading supplier of spectrochemical standards, consumables for laboratory instrumentation and product testing services. LGC Standards and VHG are an excellent fit: both companies supply reference materials and provide proficiency and consumer product testing services, [...]
California Air Resources Board Purchases Additional N2O/CO Analyzers From Los Gatos Research
May 8, 2012
MOUNTAIN VIEW, CA,-- Los Gatos Research (LGR), the leader in precision trace gas analyzers, has received an order for five more of the company's unique N2O/CO (nitrous oxide/carbon monoxide) trace gas analyzers from the California Air Resources Board (CARB). These particular instruments (part of LGR's acclaimed Enhanced Performance series) deliver extremely stringent performance specifications, including [...]
Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray
May 8, 2012
Phalanx Biotech Group, a global genomic products and service provider, announces today the completion of manufacturing and testing for a proprietary targeted chromosomal microarray (CMA) designed specifically for prenatal and postnatal detection of microdeletions and microduplications related to a spectrum of congenital disorders, especially developmental and intellectual delay disorders. CytoOneArray® is capable of detecting 264 [...]

